Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Estrofurate

From Wikipedia, the free encyclopedia
Estrofurate
Identifiers
  • [(9S,13S,14S,17S)-17-(Furan-3-yl)-17-hydroxy-13-methyl-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-yl] acetate
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC24H26O4
Molar mass378.468 g·mol−1
3D model (JSmol)
  • CC(=O)OC1=CC2=C(C=C1)C3CCC4(C(C3=CC2)CCC4(C5=COC=C5)O)C
  • InChI=1S/C24H26O4/c1-15(25)28-18-4-6-19-16(13-18)3-5-21-20(19)7-10-23(2)22(21)8-11-24(23,26)17-9-12-27-14-17/h4-6,9,12-14,20,22,26H,3,7-8,10-11H2,1-2H3/t20-,22+,23+,24-/m1/s1
  • Key:AEVUURWLDCELOV-AYVPJYCDSA-N

Estrofurate (INN, USAN; development code AY-11483; also known as 17α-(3-furyl)-estra-1,3,5(10),7-tetraene-3,17-diol 3-acetate) is a synthetic, steroidal estrogen that was synthesized in 1967 and studied in the late 1960s and early 1970s but was never marketed.[1][2] It is a relatively weak estrogen in bioassays.[3]

References

[edit]
  1. Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 503. ISBN 978-1-4757-2085-3.
  2. Banik UK, Revesz C, Herr F (April 1969). "Orally active oestrogens and progestins in prevention of pregnancy in rats". Journal of Reproduction and Fertility. 18 (3): 509–15. doi:10.1530/jrf.0.0180509. PMID 4182486.
  3. Revesz C, Banik UK, Lefebvre Y (June 1970). "AY-11483, a new type of orally active oestrogen". Journal of Reproduction and Fertility. 22 (1): 27–32. doi:10.1530/jrf.0.0220027. PMID 5421116.